Profile data is unavailable for this security.
About the company
Liaoning Chengda Biotechnology Co Ltd is a China-based company mainly engaged in the research and development, production and sales of human vaccines. The Company's products include rabies vaccine for human use and inactivated Japanese encephalitis vaccine. The Company has completed the construction of bacterial vaccine technology platform, viral vaccine technology platform, multi-component multivalent vaccine technology platform and recombinant protein vaccine technology platform. The Company mainly conducts its businesses in the domestic and foreign markets.
- Revenue in CNY (TTM)1.47bn
- Net income in CNY177.94m
- Incorporated2002
- Employees1.81k
- LocationLiaoning Chengda Biotechnology Co LtdNo. 1Xinfang Street, Hunnan New DistrictSHENYANG 110179ChinaCHN
- Phone+86 2 483782632
- Fax+86 2 423789772
- Websitehttps://www.cdbio.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chongqing Taiji Industry Group Co Ltd | 10.04bn | -352.52m | 9.90bn | 11.97k | -- | 2.80 | -- | 0.9859 | -0.8238 | -0.8238 | 18.98 | 6.42 | 0.7032 | 2.85 | 3.55 | 838,688.20 | -2.36 | 0.9924 | -6.94 | 3.04 | 26.30 | 43.37 | -3.35 | 1.08 | 0.4906 | 0.5756 | 0.5914 | 22.39 | -20.72 | 1.24 | -96.76 | -- | -3.36 | -- |
| Chengdu Olymvax Biopharmaceuticals Inc | 709.13m | 64.21m | 9.90bn | 470.00 | 153.74 | 10.32 | -- | 13.96 | 0.1587 | 0.1587 | 1.75 | 2.36 | 0.3883 | 0.654 | 1.19 | 1,508,792.00 | 3.45 | 3.25 | 5.00 | 4.81 | 92.66 | 93.62 | 8.88 | 8.11 | 1.42 | 8.30 | 0.2906 | 7.39 | 18.69 | 26.88 | 18.24 | -- | 48.00 | -- |
| Youcare Pharmaceutical Group Co Ltd | 2.55bn | -233.99m | 10.24bn | 3.28k | -- | 2.99 | -- | 4.02 | -0.5306 | -0.5306 | 5.75 | 7.62 | 0.4537 | 2.18 | 4.03 | 777,123.10 | -4.30 | 5.90 | -5.97 | 8.92 | 47.55 | 63.64 | -9.48 | 7.49 | 1.49 | -41.24 | 0.1633 | 66.99 | -9.90 | -2.48 | -33.05 | -15.40 | 19.36 | -- |
| Chongqing Genrix Biophrmctcl Co Ltd | 225.16m | -583.52m | 10.63bn | 743.00 | -- | 5.94 | -- | 47.19 | -1.59 | -1.59 | 0.6141 | 4.88 | 0.0712 | 0.3088 | 10.33 | 303,044.90 | -18.45 | -- | -19.95 | -- | 90.99 | -- | -259.16 | -- | 7.37 | -- | 0.3694 | -- | 2,384.11 | -- | 0.5049 | -- | -- | -- |
| Liaoning Chengda Biotechnology Co Ltd | 1.47bn | 177.94m | 10.79bn | 1.81k | 59.81 | 1.15 | -- | 7.34 | 0.433 | 0.433 | 3.56 | 22.54 | 0.1482 | 0.6786 | 1.24 | 813,192.10 | 1.79 | 8.07 | 1.86 | 8.36 | 79.03 | 84.98 | 12.11 | 35.75 | 19.28 | -- | 0.0013 | 44.77 | -4.22 | -0.0082 | -26.42 | -13.26 | -4.72 | -- |
| Jiangsu Sinopep Allsin Bphrmctcl Co Ltd | 1.90bn | 498.69m | 10.94bn | 2.03k | 21.71 | 3.52 | -- | 5.76 | 1.60 | 1.60 | 6.13 | 9.84 | 0.3413 | 0.9306 | 3.06 | 936,748.90 | 8.90 | 7.19 | 13.04 | 9.67 | 66.64 | 59.30 | 26.08 | 20.28 | 0.928 | 16.07 | 0.4604 | 35.89 | 57.21 | 34.33 | 148.19 | 52.76 | 31.58 | -- |
| Aurisco Pharmaceutical Co Ltd | 1.62bn | 424.54m | 10.98bn | 1.78k | 25.56 | 4.32 | -- | 6.76 | 1.06 | 1.06 | 4.07 | 6.26 | 0.4188 | 1.09 | 4.41 | 910,578.10 | 10.94 | 11.37 | 12.60 | 13.29 | 59.77 | 52.93 | 26.13 | 22.34 | 3.01 | 635.15 | 0.2806 | 31.53 | 16.89 | 20.47 | 22.59 | 13.77 | 49.45 | -- |
| Shanghai Yizhong Pharmaceutical Co Ltd | 247.05m | 22.96m | 11.30bn | 65.00 | 483.12 | 7.74 | -- | 45.75 | 0.1132 | 0.1132 | 1.22 | 7.07 | 0.163 | 0.9556 | 2.26 | 3,800,801.00 | 1.51 | 5.44 | 1.58 | 5.64 | 81.39 | 92.99 | 9.30 | 36.90 | 7.84 | -- | 0.00 | 32.30 | -51.83 | -- | -95.68 | -- | 10.96 | -- |
| Zhejiang CONBA Pharmaceutical Co., Ltd. | 6.58bn | 687.99m | 11.46bn | 8.26k | 16.96 | 1.62 | -- | 1.74 | 0.2665 | 0.2665 | 2.54 | 2.80 | 0.6617 | 2.57 | 4.70 | 796,529.00 | 7.13 | 8.51 | 9.65 | 12.74 | 51.88 | 58.64 | 10.77 | 14.12 | 1.38 | -- | 0.0532 | 41.54 | -3.23 | -0.7594 | 5.21 | -- | 1.57 | -- |
| Cansino Biologics Inc | 971.83m | -142.03m | 11.61bn | 1.11k | -- | 3.06 | -- | 11.95 | -0.5455 | -0.5455 | 3.92 | 21.37 | 0.1271 | 0.5861 | 1.38 | 879,482.50 | -1.86 | -4.08 | -2.29 | -5.38 | 78.80 | 45.31 | -14.62 | -27.51 | 3.29 | -- | 0.2242 | -- | 137.01 | 226.43 | 74.45 | -- | 31.38 | -- |
Data as of Feb 11 2026. Currency figures normalised to Liaoning Chengda Biotechnology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
2.73%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 2.04m | 0.49% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 2.03m | 0.49% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 1.56m | 0.37% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 1.45m | 0.35% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 1.13m | 0.27% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 907.07k | 0.22% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2025 | 741.82k | 0.18% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 531.92k | 0.13% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 514.85k | 0.12% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 480.63k | 0.12% |
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
